Next-generation cancer tests are being developed here in Houston, and the HBJ pulled back the curtain on how one partnership ...

SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, and The University of Texas MD Anderson ...

The University of Texas MD Anderson Cancer Center and SOPHiA GENETICS today announced a strategic collaboration that unites ...

LIXTE Biotechnology Holdings (NASDAQ: LIXT) announced an expansion of its collaboration with The University of Texas MD ...

Investing.com -- Sophia Genetics SA (NASDAQ:SOPH) stock rose 4.2% on Wednesday after the AI-driven precision medicine company announced a strategic collaboration with The University of Texas MD ...

Lynch Syndrome (LS) is a common hereditary condition that significantly increases the lifetime risk of developing multiple cancersNOUS-209 is an ...

The preventive immunization Nous-209 works in an initial trial with patients who have 17 times the risk of developing tumors compared to the general population ...

Anderson inks partnership powered by AI cancer diagnostics to develop genomic tools that improve cancer diagnosis and treatment decisions.

Therapies that target the utilization of fat by tumors and activate a type of cell death dependent on fat molecules may be a ...

Therapies that target the utilization of fat by tumors and activate a type of cell death dependent on fat molecules may be a ...

The university says the gift from Austin residents Tench and Simone Coxe is one of the largest in UT Austin's history.